Navigation Links
DW Healthcare Partners Announces New CEO on Heels of Increased Investment in Institutional Pharmacy Sector
Date:1/18/2011

PARK CITY, Utah, Jan. 18, 2011 /PRNewswire/ -- DW Healthcare Partners (DWHP), a leading private equity firm specializing in select healthcare sectors, announced the appointment of Bradley Lanham as the new Chief Executive Officer of BGS Holdings.  Through BGS Holdings, DWHP has now completed acquisitions of institutional pharmacies specializing in long term care and hospice in growth markets including Texas, Nevada, Utah, Idaho and Colorado.

"Brad's appointment as CEO represents the pinnacle step towards consolidating and advancing our interests in the long term care and hospice pharmacy markets," said Doug Schillinger, DWHP Managing Director and BGS Holdings Board Member.  Schillinger continued, "With the recent and largest acquisition of Spectrum Pharmacy Services in Nevada, we now have achieved five transactions that will serve as the platform for solid growth in all five markets as well as contiguous geographic opportunities.  We are thrilled that Brad shares our vision and as CEO, he will lead an executive team with tremendous experience in this space."

A graduate of the University of Texas, Austin with a degree in Pharmacy, Lanham spent 18 years at PharMerica, the last 5 years as Senior Vice President of Operations, with direct responsibility for geographic regions totaling $600 million in revenues.  Most recently, Lanham served at Bristol Myers Squibb, leading the drug maker's strategy to expand its presence in the Long Term Care market.

In related news, DWHP announced the transition of Drew McCartney from interim CEO of BGS Holdings back into the equity firm's Executive In Residence (EIR) program.  Doug Schillinger added, "Drew has been a superb partner assisting us in the successful evolution of our plans for BGS.  From his leadership on the Spectrum acquisition to his role in selecting the New CEO, we benefited from Drew's seasoned executive skills and we look forward to his ongoing role with DWHP on future investments."

Formed in 2002, DW Healthcare Partners is a healthcare focused private equity firm with over $250 million under management. DWHP invests in healthcare companies generating over $3 million in EBITDA.  DWHP's extensive knowledge of the healthcare market allows the firm to quickly evaluate and complete growth transactions. DWHP's experience owning and operating healthcare businesses provides for an understanding for the operational and strategic issues confronting business owners and can help accelerate growth and the creation of substantial shareholder value.


'/>"/>
SOURCE DW Healthcare Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
2. GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimers Disease
3. Millennium Laboratories to Provide UnitedHealthcares Nationwide Network of Physicians Drug Monitoring and Pain Management Services
4. DST HealthCare Launches Medical Drug Management Service™
5. Siemens Launches PEP, a Personalized Education Plan for Clinical Laboratory and Healthcare Professionals
6. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Ventus Medical to Present at JP Morgan 29th Annual Healthcare Conference
8. UL White Paper Examines Key Implications of Growing Home Healthcare Industry
9. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
10. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
11. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... YORK , March 29, 2017 Global intravenous ... US$ 3 billion by 2021, growing at a CAGR of ... iron prescribed by a doctor to treat anemia or other ... iron level in the body. However, in some cases, oral ... the body and intravenous (IV) iron therapy comes into the ...
(Date:3/29/2017)... March 29, 2017  BioSpecifics Technologies Corp. (NASDAQ: ... to develop collagenase based-therapies with a first in ... as XIAFLEX ®  in the U.S. and Xiapex ... a corporate overview at the upcoming 16 th ... 5, 2017 at 8:00 a.m. ET in ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... value in 2016. There are currently three proton therapy centers in ... more patients. In Italy , the first patients were ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... BC (PRWEB) , ... March 29, 2017 , ... ... makeover services with or without a referral to new patients from Burnaby, BC. ... or other full mouth reconstruction services, can see the esteemed team at ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without ... efficiently, compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... as it continues developing an ANSI-approved, consensus-based American National Standard for Good ... to publish the first ANSI-approved GMP standard for dietary supplements this spring, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
Breaking Medicine News(10 mins):